These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 365193

  • 21. Acute rejection and late renal transplant failure: risk factors and prognosis.
    Pallardó Mateu LM, Sancho Calabuig A, Capdevila Plaza L, Franco Esteve A.
    Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii38-42. PubMed ID: 15192134
    [Abstract] [Full Text] [Related]

  • 22. Renal transplantation at the University of Minnesota during the 1980s.
    Fryd DS, Migliori R, Simmons RL, Chavers B, Dunn D, Payne W, Canafax DM, Sutherland DE, So SS, Mauer SM.
    Clin Transpl; 1987 Jun; ():167-81. PubMed ID: 3154396
    [Abstract] [Full Text] [Related]

  • 23. An analysis of predictors of long-term cadaveric renal allograft survival.
    Cole E, Naimark D, Aprile M, Wade J, Cattran D, Pei Y, Fenton S, Robinette M, Zaltsman J, Bear R.
    Clin Transplant; 1995 Aug; 9(4):282-8. PubMed ID: 7579734
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Experience with 130 consecutive renal transplants in the Middle East with special reference to histocompatibility matching, antirejection therapy with antilymphocyte globulin (ALG), and prolonged preservation of imported cadaveric grafts.
    Abouna GM, Kumar MS, White AG, Daddah S, John P, Samhan M, Omar OF, Kusma G.
    Transplant Proc; 1984 Aug; 16(4):1114-7. PubMed ID: 6380057
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF, Stern S, Beizer R, Sklar L, Bannett A.
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of Minnesota antilymphocyte globulin and OKT3 for induction of immunosuppression in renal transplant patients.
    Light JA, Khawand N, Ali A, Brems W, Aquino A.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1738-40. PubMed ID: 2652569
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of severe aplastic anemia].
    Gratwohl A, Osterwalder B, Nissen C, Leibundgut U, Signer E, Lüthy A, Jeannet M, Speck B.
    Schweiz Med Wochenschr; 1981 Oct 10; 111(41):1520-2. PubMed ID: 7031870
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Medical research council trial of antilymphocyte globulin in renal transplantation. A multicenter randomized double-blind placebo controlled clinical investigation.
    Bell PR, Blamey RW, Briggs JD, Castro JE, Hamilton DN, Knapp MS, Salaman JR, Sells RA, Williams G, Gowans JL, Peto R, Richards S, Phillips AW, Weinberg AL, Freestone DS.
    Transplantation; 1983 Jun 10; 35(6):539-45. PubMed ID: 6346595
    [Abstract] [Full Text] [Related]

  • 34. ALG treatment of steroid-resistant rejection in patients receiving cyclosporine.
    Matas AJ, Tellis VA, Quinn T, Glichlick D, Soberman R, Weiss R, Karwa G, Veith FJ.
    Transplantation; 1986 May 10; 41(5):579-83. PubMed ID: 3518163
    [Abstract] [Full Text] [Related]

  • 35. The increasing importance of chronic rejection as a cause of renal allograft failure.
    Dennis MJ, Foster MC, Ryan JJ, Burden RP, Morgan AG, Blamey RW.
    Transpl Int; 1989 Dec 10; 2(4):214-7. PubMed ID: 2697211
    [Abstract] [Full Text] [Related]

  • 36. A controlled clinical trial of treatment with ALG in established rejection of renal allografts.
    Birkeland SA.
    Acta Med Scand; 1975 Dec 10; 198(6):489-96. PubMed ID: 1108600
    [Abstract] [Full Text] [Related]

  • 37. Prolonged survival time of canine xenografts using a new schedule of horse--anti-dog lymphocytic globulin (ALG) therapy.
    Brendel W, Duswald KH, von Scheel J, Chaussy C, Sollinger HW, Hammer C.
    Transplant Proc; 1977 Mar 10; 9(1):379-81. PubMed ID: 325782
    [No Abstract] [Full Text] [Related]

  • 38. The effect of serum ALG concentrations on results following renal transplantation.
    Howard RJ, Condie RM, Sutherland DE, Simmons RL, Najarian JS.
    Ann Surg; 1977 Nov 10; 186(5):619-24. PubMed ID: 335988
    [Abstract] [Full Text] [Related]

  • 39. Reduced incidence and severity of accelerated graft atherosclerosis in cardiac transplant recipients treated with prophylactic antilymphocyte globulin.
    Dresdale AR, Kraft PL, Paone G, McFarland T, Levine TB, delBusto R, Lutz S, Drost C, Silverman NA.
    J Cardiovasc Surg (Torino); 1992 Nov 10; 33(6):746-53. PubMed ID: 1287016
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.